Chemical Biology & Drug Design · 2010 · 64 citations · 34 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryChemical Library DesignChemical Space ExplorationDe Novo Drug DesignLead Compound DesignMolecular DockingPeptidomimetic DesignAntagonistic InteractionsCyclic PeptidomimeticsFocused Library SynthesisLibrary Design For PeptidomimeticsOptimization Of Drug-like PropertiesPeptidomimetic Library SynthesisSmall-molecule Library ConstructionVirtual Screening Space
1,4-Thienodiazepine-2,5-diones have been synthesized via the Ugi-Deprotection-Cyclization (UDC) approach starting from Gewald 2-aminothiophenes in a convergent and versatile manner. The resulting scaffold is unprecedented, cyclic, and peptidomimetic with four points of diversity introduced from readily available starting materials. In addition to eighteen synthesized and characterized compounds, a virtual compound library was generated and evaluated for chemical space distribution and drug-like properties. A small focused compound library of 1,4-thienodiazepine-2,5-diones has been screened for the activity against p53-Mdm2 interaction. Biological evaluations demonstrated that some compounds exhibited promising antagonistic activity.
34
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
Structure-Based Design of Potent Non-Peptide MDM2 Inhibitors
Ke Ding, Yipin Lu, Zaneta Nikolovska‐Coleska et al. · Journal of the American Chemical Society · 2005 · 649 citations
Susumu Mori, Chitrananda Abeygunawardana, Mike Johnson et al. · Journal of Magnetic Resonance Series B · 1995 · 637 citations · Full text